Our first-of-its-kind Propsci practice draws on the deep legal and market experience of lawyers in our Real Estate and Life Sciences groups to help clients capture opportunities where these industries come together. That covers developing, leasing, acquiring, structuring, financing, owning, and operating real estate for life sciences and biotech uses, including R&D and manufacturing.
We partner with clients throughout the corporate lifecycle, advising on everything from pre-Series A financings and exits via IPO or M&A to leasing transactions and the construction and financing of life sciences facilities. And we understand the factors that influence the formation of life sciences clusters, including workforce issues, availability of private and public funding, innovation capacity, and academic institutional needs.
Our comprehensive coverage includes:
- Company and fund formation
- IP and licensing
- Leasing (landlord and tenant representation)
- Healthcare regulatory
- Development and permitting
- Design and construction
- Acquisitions and dispositions
- Mergers and acquisitions
- Environmental law
Connect with our PropSci team and let us know how we can help.
Perseverance in the Wake of Adversity
The year 2020 was a transformative one for the life sciences industry. 2021 has been no different. Over the past two years, the life sciences industry has found itself at the forefront of the public eye as the world turned to every corner of the industry to map out solutions to the global pandemic. At Goodwin, we are incredibly proud to serve as legal counsel and trusted business advisors to our extraordinary clients across the life sciences ecosystem.